With a market capitalization (market cap) of $5.44B — a measure of how much the company is worth — MiniMed Group, Inc. Common Stock is the 1356th most valuable company in Healthcare as of August 18, 2026. Shares trade at $19.36, down +0.87% on the day.
of 2,587
price ÷ annual EPS
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
MiniMed Group, Inc. specializes in designing, producing, and distributing a broad spectrum of medical technologies and solutions aimed at effective diabetes management. The company's diverse portfolio features essential tools like insulin pumps, continuous glucose monitoring (CGM) systems, infusion sets, specialized software platforms, and various supplementary accessories. These innovations are crafted to enable both patients and healthcare providers to accurately monitor and precisely regulate blood glucose levels. The enterprise was established in 1983 by Alfred E. Mann and is currently headquartered in Northridge, California.
Visit websiteAs of August 18, 2026, MiniMed Group, Inc. Common Stock (MMED) is worth $5.44B — this is its market capitalization, the total value of all its outstanding shares.
MiniMed Group, Inc. Common Stock’s market cap is $5.44B, which ranks it #1356 among the most valuable companies in the Healthcare sector tracked on MarketCapLens.
MiniMed Group, Inc. Common Stock (MMED) shares trade at $19.36, down 0.87% on the day, as of August 18, 2026.
Fundamentals are annual. Figures labeled with their fiscal year.
FY 2025